Allianz Asset Management
ACHV icon

Allianz Asset Management’s Achieve Life Sciences ACHV Stock Holding History

Allianz Asset Management’s Portfolio ACHV Stock Details ACHV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		– Sell
-329
Closed -$869K – 2479
2015
Q4 		$869K Hold
329
– – ﹤0.01% 2029
2015
Q3 		$1.61M Buy
329
+14
+4% +$84.3K ﹤0.01% 1661
2015
Q2 		$1.61M Sell
315
-160
-34% -$794K ﹤0.01% 1790
2015
Q1 		$2.25M Hold
475
– – ﹤0.01% 1487
2014
Q4 		$2.39M Buy
475
+237
+100% +$1.16M ﹤0.01% 1473
2014
Q3 		$1.4M Hold
238
– – ﹤0.01% 1570
2014
Q2 		$1.95M Buy
238
+120
+102% +$1.47M ﹤0.01% 1216
2014
Q1 		$3.06M Hold
118
– – ﹤0.01% 1080
2013
Q4 		$2.17M Hold
118
– – ﹤0.01% 1190
2013
Q3 		$2.41M Hold
118
– – ﹤0.01% 1140
2013
Q2 		$2.55M Buy
+118
New +$2.64M ﹤0.01% 1131

Other funds holding ACHV

WC
Wexford Capital West Palm Beach, Florida $782M AUM 62.56% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
VF
Virtu Financial New York $3.18B AUM 65.92% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PAM
Panagora Asset Management Boston, Massachusetts $32.6B AUM 52.29% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
FDCDDQ
Federation des caisses Desjardins du Quebec Levis, Quebec, Canada $32.7B AUM 35.71% 1-Year Est. Return

Allianz Asset Management's ACHV Position: Q1 2016 in Review

Allianz Asset Management sold out of Achieve Life Sciences (ACHV) in Q1 2016, closing a stake of 329 shares — an estimated $869K sold.

Allianz Asset Management first reported a position in ACHV in Q2 2013 and held it in 11 quarters. The position peaked at $3.06M in Q1 2014. 38 funds tracked by Wall St. Rank hold ACHV as of Q1 2016.

  • Allianz Asset Management reported no remaining Achieve Life Sciences position as of Q1 2016 after selling out during the quarter.
  • Allianz Asset Management sold 329 Achieve Life Sciences shares in Q1 2016, an estimated $869K.
  • Allianz Asset Management first reported a position in Achieve Life Sciences in Q2 2013 and held it in 11 quarters.
  • Allianz Asset Management's Achieve Life Sciences position peaked at $3.06M in Q1 2014.
  • 38 funds tracked by Wall St. Rank held Achieve Life Sciences as of Q1 2016.

Based on Allianz Asset Management's 13F filing for Q1 2016, filed 13 May 2016.